Ataxin-2 as potential disease modifier in C90RF72 expansion carriers (2014)
Source: Neurobiology of aging. Unidade: FM
Subjects: MUTAÇÃO GENÉTICA, DOENÇAS (METABOLISMO), NEURÔNIOS MOTORES (PATOLOGIA)
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
VAN BLITTERSWIJK, Marka et al. Ataxin-2 as potential disease modifier in C90RF72 expansion carriers. Neurobiology of aging, v. 35, n. 3, p. 2421e13-2421e17, 2014Tradução . . Disponível em: https://doi.org/10.1016/j.neurobiolaging.2014.04.016. Acesso em: 14 out. 2024.APA
van Blitterswijk, M., Mullen Bianca,, Heckman, M., Grinberg, L. T., Backer, M., Hernandez, M. de J., et al. (2014). Ataxin-2 as potential disease modifier in C90RF72 expansion carriers. Neurobiology of aging, 35( 3), 2421e13-2421e17. doi:10.1016/j.neurobiolaging.2014.04.016NLM
van Blitterswijk M, Mullen Bianca, Heckman M, Grinberg LT, Backer M, Hernandez M de J, Brown P, Murray M, Hsiung GY, Stewart H, Karydas A, Finger E, Kertesz A, Bigio E, Weintraub S, Mesulam M, Hatanpaa K, White III C, Neumann M, Strong M, Beach T, Wszolek Z, Lippa C, Caselli R, Petrucelli L, Josephs K, Parisi J, Knopman D, Peterson R, Mackenzie I, Seeley william, Miller B, Boylan K, Graff-Radford N, Boeve B, Dickson D, Rademarkers R. Ataxin-2 as potential disease modifier in C90RF72 expansion carriers [Internet]. Neurobiology of aging. 2014 ; 35( 3): 2421e13-2421e17.[citado 2024 out. 14 ] Available from: https://doi.org/10.1016/j.neurobiolaging.2014.04.016Vancouver
van Blitterswijk M, Mullen Bianca, Heckman M, Grinberg LT, Backer M, Hernandez M de J, Brown P, Murray M, Hsiung GY, Stewart H, Karydas A, Finger E, Kertesz A, Bigio E, Weintraub S, Mesulam M, Hatanpaa K, White III C, Neumann M, Strong M, Beach T, Wszolek Z, Lippa C, Caselli R, Petrucelli L, Josephs K, Parisi J, Knopman D, Peterson R, Mackenzie I, Seeley william, Miller B, Boylan K, Graff-Radford N, Boeve B, Dickson D, Rademarkers R. Ataxin-2 as potential disease modifier in C90RF72 expansion carriers [Internet]. Neurobiology of aging. 2014 ; 35( 3): 2421e13-2421e17.[citado 2024 out. 14 ] Available from: https://doi.org/10.1016/j.neurobiolaging.2014.04.016
